Palomar/Laserscope
This article was originally published in The Gray Sheet
Executive Summary
Palomar grants Laserscope a non-exclusive 7.5% royalty-bearing sublicense to patents in the field of laser hair removal, including U.S. Patent No. 5,595,568 "Permanent Hair Removal Using Optical Pulses," and No. 5,735,844 entitled "Hair Removal Using Optical Pulses." Palomar previously granted a 7.5% sublicense for the same patents to Coherent (1"The Gray Sheet" May 3, 1999, p. 20)
You may also be interested in...
Palomar Medical Technologies
Laser hair removal device firm's planned recapitalization includes a one-for-seven reverse stock split. At an April 21 meeting shareholders also approved the sale of the firm's Star Medical Technologies semiconductor laser subsidiary to Coherent for $65 mil. in cash and an ongoing 7.5% royalty. Palomar owns 82% of Star and anticipates a net gain of about $49 mil. before taxes. Closing of the deal, announced in December, is expected "shortly" ("The Gray Sheet" Dec. 14, 1998, p. 8)
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.